Related Experiment Video
Updated: Mar 12, 2026
Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata
Published on: November 23, 2017
Assessment of Growth 6 Years after the Norwood Procedure
Phillip T Burch1, Chitra Ravishankar2, Jane W Newburger3
1Departments of Surgery, Primary Children's Hospital, University of Utah, Salt Lake City, UT.
Insights
Children with hypoplastic left heart syndrome (HLHS) show lower weight and height z-scores by age 6. However, their body mass index (BMI) is comparable to peers, with males exhibiting the most significant BMI gains.
Area of Science:
- Pediatric Cardiology
- Growth and Development Studies
- Congenital Heart Disease Research
Background:
- Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect impacting left heart development.
- Long-term growth patterns in HLHS survivors require further investigation.
Purpose of the Study:
- To assess anthropometric measurements in children with HLHS at 6 years of age.
- To compare growth parameters of HLHS patients to normative data.
Main Methods:
- Analysis of age-adjusted z-scores for weight, height, and body mass index (BMI) at 6 years.
- Comparison of anthropometric data against a normative population.
Main Results:
- Patients with HLHS exhibited mean age-adjusted z-scores below the normative population for weight and height.
- Body mass index (BMI) z-scores were similar to the normative population.
- Male patients demonstrated the most substantial increase in BMI z-scores over time.
Conclusions:
- HLHS survivors may experience growth deficits in weight and height by age 6.
- While overall BMI is comparable, gender-specific trends in BMI changes warrant attention in HLHS management.
Abstract:
At 6 years of age, patients with hypoplastic left heart syndrome had mean age-adjusted z-scores for weight and height below the normative population, and body mass index was similar to the normative population. Males had the greatest increase in z-scores for body mass index.
Trial Registration:
ClinicalTrials.gov: NCT00115934.
